Amendment116th Congress
An amendment numbered 9 printed in Part B of House Report 116-334 to require drug companies to disclose truthful and non-misleading pricing information about prescription drugs and biological products when they advertise these products directly to consumers.
- Amendment Number
- 719
- Description
- An amendment numbered 9 printed in Part B of House Report 116-334 to require drug companies to disclose truthful and non-misleading pricing information about prescription drugs and biological products when they advertise these products directly to consumers.
- Purpose
- An amendment numbered 9 printed in Part B of House Report 116-334 to require drug companies to disclose truthful and non-misleading pricing information about prescription drugs and biological products when they advertise these products directly to consumers.
- Congress
- 116
- Type
- HAMDT
- Latest Action Date
- Dec 12, 2019
- Latest Action Text
- On agreeing to the Finkenauer amendment (A009) Agreed to by voice vote.
- Latest Action Time
- 12:21:05
- Submitted Date
- Dec 12, 2019
- Chamber
- House of Representatives
- Update Date
- Feb 8, 2022